Back to Journals » OncoTargets and Therapy
OncoTargets and Therapy
Editor-in-Chief: Professor Gaetano Romano
OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (6757)
- Volume 19, 2026 (72)
- Volume 18, 2025 (105)
- Volume 17, 2024 (142)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Latest articles:
- 5 records -
Survival Outcomes and Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated First-Line mFOLFOXIRI Plus Bevacizumab: A Real-World Study in Vietnam
Mai NTK, Trinh HL, Pham AT, Nguyen HX, Nguyen HV, Tran AD, Nguyen TTP
OncoTargets and Therapy 2026, 19:621382
Published Date: 18 July 2026
Small Nucleolar RNAs (snoRNAs) in Cancer: From Biogenesis to Clinical Potential
Zhang H, He C, Chen D, Feng J, He X, Zhang Z
OncoTargets and Therapy 2026, 19:600733
Published Date: 9 July 2026
Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review
Xia X, Yu T, Sun H, Li J, Liu F, Zhu X
OncoTargets and Therapy 2026, 19:606668
Published Date: 9 July 2026
ELOVL6 Promotes the Proliferation and Migration of Oral Squamous Cell Carcinoma Cells Through Fatty Acid Remodelling and ROS Modulation in vitro
You J, Li L, Yang J, Xu J, Qian B, Qian L
OncoTargets and Therapy 2026, 19:592523
Published Date: 26 June 2026
Multi-Omics Analysis Identifies Phosphoglucomutase 2 as a Potential Target to Alleviate Chemoradiotherapy Resistance in Cervical Cancer Cells
Yang H, Zheng Q, Li X, Wang J
OncoTargets and Therapy 2026, 19:613657
Published Date: 16 June 2026